Today, cannabis company Aphria (NYSE: APHA) announced that its subsidiary in Malta, ASG Pharma, has received the European Union's Good Manufacturing Practices (GMP) certification. This certification was issued by the Malta Medicines Authority and allows Aphria to produce and research medical marijuana products at its facility. Aphria can now import cannabis resin and dried flowers, and package and distribute GMP-compliant cannabis products all across Europe. Read More...
Aphria Subsidiary Earns European Union’s GMP Certification
Today, cannabis company Aphria (NYSE: APHA) announced that its subsidiary in Malta, ASG Pharma, has received the European Union’s Good Manufacturing Practices (GMP) certification. This certification was issued by the Malta Medicines Authority and allows Aphria to produce and research medical marijuana products at its facility. Aphria can now import cannabis resin and dried flowers, and package and distribute GMP-compliant cannabis products all across Europe.
Add Comment